These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1808420)

  • 1. [Recognan therapy of motor disturbances in patients with stroke].
    Lebedeva NV; Lunev DK; Shvedkov VV; Solov'ev OI; Smirnova IN; Altunina MN
    Klin Med (Mosk); 1991 Nov; 69(11):83-4. PubMed ID: 1808420
    [No Abstract]   [Full Text] [Related]  

  • 2. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the effect of CDP in patients with motor disorders of cerebral origin].
    Asirón Yribarren PJ; Bascuas Asta JL; Marín Górriz F; Marín Redondo J; Noguera Lobera AR; Ramos Cristóbal JA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(1):97-104. PubMed ID: 654990
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
    De Gregorio G; Armeli G; Restivo S; Francolino A
    Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathological aging of the brain. Personal observations on the use of citicoline].
    Palleschi M; Capobianco G
    Clin Ter; 1988 Apr; 125(2):121-8. PubMed ID: 2973933
    [No Abstract]   [Full Text] [Related]  

  • 6. [CDP choline and cerebrovascular insufficiency in the elderly. Clinical study of 40 patients undergoing prolonged treatment].
    Merchan C; Berchicci R; Cuzzoni G; Pecorini M
    Minerva Cardioangiol; 1985 Mar; 33(3):145-8. PubMed ID: 4010981
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the effects of citicoline in chronic cerebrovascular diseases].
    Sinforiani E; Trucco M; Pacchetti C; Gualtieri S
    Minerva Med; 1986 Jan; 77(1-2):51-7. PubMed ID: 3511406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from ischemia-reperfusion damage in patients with stroke: the role of rutin and GSH.
    Ortolani O; Caggiano M; Mannelli R; Gogliettino A; Tufano R
    Transplant Proc; 1995 Oct; 27(5):2877-8. PubMed ID: 7482952
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy].
    Rossi M; Zanardi M
    Clin Ter; 1993 Feb; 142(2):141-4. PubMed ID: 8472528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocytopenia secondary to citicholine].
    Marcos Sánchez F; Juárez Ucelay F; Aguirre de Cárcer A; Moreiras Jiménez JL
    Med Clin (Barc); 1987 Apr; 88(16):653. PubMed ID: 3600074
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of citicoline in high dosages in acute cerebrovascular disease].
    Centrone G; Ragno G; Calicchio G
    Minerva Med; 1986 Mar; 77(11):371-3. PubMed ID: 3703329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effects of cyticholine (cytidine-diphospho-choline) in Parkinsonian syndrome].
    Ruggieri S; Zamponi A; Casacchia M; Agnoli A
    Clin Ter; 1976 Sep; 78(6):515-25. PubMed ID: 797506
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the carotid atheromatous plaques and in flow conditions in patients with cerebrovascular pathology after treatment with CDP choline. Clinico-instrumental study].
    Bellagamba G; Gentili G; Caratelli L; Balestrini F; Fratalocchi N; Assouad C; Moretti V; Dragonetti G; Evangelisti A; Salvolini U
    Minerva Cardioangiol; 1984; 32(7-8):483-8. PubMed ID: 6387537
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of citicoline in the study of chronic cerebrovascular diseases].
    Grasso A; Ventimiglia A; Sofia V; Arena M; Campo G
    Minerva Med; 1988 Sep; 79(9):791-6. PubMed ID: 2902537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic disturbances and the means for their pharmacological correction in transient disorders of cerebral circulation and ischemic stroke].
    Vinichuk SM
    Vrach Delo; 1986 Feb; (2):37-41. PubMed ID: 3705565
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapeutic action of kavinton electrophoresis in cerebrovascular diseases].
    Musaev AV; Balakishieva FK; Nabiev NN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (3):19-22. PubMed ID: 9771139
    [No Abstract]   [Full Text] [Related]  

  • 19. [The efficacy of recognan in the early stage of ischemic stroke].
    Mashin VV; Belova LA; Dudikov EM; Bergelson TM; Lankov VA; Zakuraeva KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):44-48. PubMed ID: 29171488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.
    Franco-Maside A; Caamaño J; Gómez MJ; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):597-607. PubMed ID: 7760585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.